In this episode, Rick and Greg explore effective weight loss options outside of GLP-1 medications, offering a practical and medically grounded look at alternatives for patients who cannot tolerate or access these newer therapies.

They begin with a discussion of weight loss physiology, emphasizing the roles of hormones, appetite regulation, and metabolic signaling—highlighting why willpower alone is often insufficient for long-term success.

The episode then reviews several evidence-based options, including:

• Phentermine, a long-standing and cost-effective stimulant that reduces appetite and increases energy
• Topiramate, a medication that targets cravings and reward pathways in the brain
• Combination therapy (phentermine + topiramate) for enhanced outcomes
• Orlistat, which reduces fat absorption but carries notable gastrointestinal side effects

They also discuss off-label use of metformin, particularly for improving insulin sensitivity and stabilizing metabolic function, as well as berberine, a supplement with similar mechanisms.

As part of a comprehensive approach to weight loss, Rick and Greg also highlight the role of targeted nutritional supplementation. Their supplement line, available at GetWeightWise.com, is designed to support individuals navigating medically guided weight loss—helping address common challenges such as energy levels, metabolic support, and medication-related side effects.

A key focus of the episode is the importance of working with a medical provider, as studies and clinical experience consistently show improved outcomes with supervision, accountability, and individualized treatment plans.

The episode concludes with insights into emerging evidence that personalized dosing strategies—especially with weight loss medications—can significantly improve results compared to standardized protocols.

Disclaimer:

This podcast is for informational and educational purposes only and does not constitute medical advice. Listeners should consult their healthcare provider before making any medical decisions.